Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Mottet

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Crohn'S & Colitis|December 18, 2014
Acceptance of inflammatory bowel disease treatment recommendations based on appropriateness ratings: do practicing gastroenterologists agree with experts?Valérie Pittet, Michel H Maillard, Stéphanie Lauvergeon, et al.
Digestion|October 12, 2012
First-line therapies in inflammatory bowel diseaseMarc Girardin, Michael Manz, Christine Manser, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort studyPascal Juillerat, Valérie Pittet, Jean-Luc Bulliard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitisHolm H Uhlig, Janine Coombes, Christian Mottet, et al.
Journal of Crohn'S & Colitis|May 14, 2013
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panelValerie Pittet, Florian Froehlich, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|January 28, 2014
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitisMichel H Maillard, Murielle Bortolotti, John-Paul Vader, et al.
Inflammatory Bowel Diseases|October 21, 2016
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel DiseaseChristian Mottet, Alain M Schoepfer, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
The American Journal of Gastroenterology|June 18, 2019
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel DiseaseLaure F Pittet, Charlotte M Verolet, Pierre Michetti, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Crohn'S & Colitis|December 18, 2014
Acceptance of inflammatory bowel disease treatment recommendations based on appropriateness ratings: do practicing gastroenterologists agree with experts?Valérie Pittet, Michel H Maillard, Stéphanie Lauvergeon, et al.
Digestion|October 12, 2012
First-line therapies in inflammatory bowel diseaseMarc Girardin, Michael Manz, Christine Manser, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort studyPascal Juillerat, Valérie Pittet, Jean-Luc Bulliard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitisHolm H Uhlig, Janine Coombes, Christian Mottet, et al.
Journal of Crohn'S & Colitis|May 14, 2013
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panelValerie Pittet, Florian Froehlich, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|January 28, 2014
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitisMichel H Maillard, Murielle Bortolotti, John-Paul Vader, et al.
Inflammatory Bowel Diseases|October 21, 2016
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel DiseaseChristian Mottet, Alain M Schoepfer, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
The American Journal of Gastroenterology|June 18, 2019
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel DiseaseLaure F Pittet, Charlotte M Verolet, Pierre Michetti, et al.
Pageof 6